VCYT — VERACYTE, INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1384101 ·
Last close
$41.47
Market Cap
$3.33B
52W High
$60.91
52W Low
$40.10
ADV30
1,304,298
Next earnings
2026-07-30
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 139,071,000 | 101,159,000 | 22,646,000 | 28,707,000 | 1,436,400,000 | 263,136,000 | 91,994,000 |
| Dec 2025 | 140,636,000 | 101,973,000 | 39,908,000 | 41,149,000 | 1,406,019,000 | 362,578,000 | 96,443,000 |
| Sep 2025 | 131,872,000 | 91,282,000 | 23,112,000 | 19,137,000 | 1,367,787,000 | 315,573,000 | 110,120,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$166,160,000
Investing CF
$-85,352,000
Financing CF
$-4,367,000
CapEx
$-10,820,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.41
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-348,923,000
Inventory
$21,416,000
Receivables
$50,112,000
ST Investments
$175,924,000
EBIT TTM
$90,747,000
Pretax Income TTM
$90,747,000
Interest Exp TTM
$0
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$561,900,032
EBITDA
$113,515,000
Free Cash Flow
$106,230,872
Enterprise Value
$2,956,206,848
Total Cash
$485,232,000
Total Debt
$40,107,000
Shares Out
80,390,731
Trailing EPS
$1.40
Book Value
$17.28
ROE
8.8%
ROA
4.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 517,145,000 | 78,282,000 | 66,353,000 | 1,406,019,000 | 96,443,000 | — | 136,307,000 |
| Dec 2024 | 445,764,000 | 19,510,000 | 24,138,000 | 1,300,035,000 | 124,069,000 | — | 75,096,000 |
| Dec 2023 | 361,051,000 | -17,446,000 | -74,404,000 | 1,114,906,000 | 70,804,000 | — | 44,222,000 |
| Dec 2022 | 296,536,000 | -35,340,000 | -36,560,000 | 1,156,422,000 | 81,222,000 | — | 7,535,000 |
TTM Snapshot
Revenues TTM
$341,930,000
NetIncome TTM
$-37,315,000
OpCashFlow TTM
$0
Assets (Latest)
$1,300,035,000
Forward EPS
$1.95
Max Pain — expiry 2026-12-18
max pain strike: $35.00 · spot: $41.47 · call oi: 2,651 · put oi: 97
Expected Move to 2026-12-18:
±$10.72
(25.86%) —
implied range
$30.75 –
$52.20
· ATM straddle on $40.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GRAL | GRAIL, Inc. | $3.42B | $76.58 | — |
| OPCH | Option Care Health, Inc. | $3.55B | $23.67 | — |
| NHC | NATIONAL HEALTHCARE CORP | $3.58B | $228.38 | — |
| AVAH | Aveanna Healthcare Holdings, Inc. | $2.99B | $13.70 | — |
| BKD | Brookdale Senior Living Inc. | $2.89B | $12.12 | — |
News headlines (Yahoo Finance, 1h cache)
Is Veracyte (VCYT) Fully Valued After Raising 2026 Revenue Guidance?
2026-07-31 10:06 · Yahoo
Veracyte Inc (VCYT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Launches ...
2026-07-31 05:03 · Yahoo
Veracyte (VCYT) Rises with Upward Guidance Revision and Earnings Beat
2026-07-30 13:17 · Yahoo
Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline
2026-07-23 14:00 · Yahoo
Reasons to Retain Doximity Stock in Your Portfolio for Now
2026-08-24 18:47 · Yahoo
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
2026-08-24 18:47 · Yahoo
AMN Stock Rallies Nearly 119% YTD: What's Behind the Momentum?
2026-08-24 18:23 · Yahoo
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
2026-08-24 15:15 · Yahoo
Is it the Right Time to Retain DGX Stock in Your Portfolio?
2026-08-21 15:43 · Yahoo
Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now?
2026-08-21 13:54 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.